Subscribe To
Gamida cell to present corporate highlights at multiple upcoming investor conferences
BOSTON--( BUSINESS WIRE )--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic ...
November 23, 2022, 8:00 am
Urogen pharma: jelmyto sales growing steadily, concerns remain
Shares have lost nearly two-thirds of their value over the past 3 years. RTGel platform is a great fit for bladder ...
November 21, 2022, 1:30 pm
Cardiff oncology to present at upcoming investor conferences
SAN DIEGO , Nov. 21, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to ...
November 21, 2022, 10:52 am
Gsk second-line applications of new cancer drug will be restricted
GSK PLC (LSE:GSK, NYSE:GSK) said the second-line applications of its cancer drug will be limited in scope. The front-line use of Zejula, which has bee...
November 11, 2022, 2:28 am
Celcuity inc. schedules release of third quarter 2022 financial results and webcast/conference call
MINNEAPOLIS, MN/ ACCESSWIRE / November 3, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targete...
November 3, 2022, 8:50 am
Erasca to present at the morgan stanley global healthcare conference
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discoveri...
September 9, 2022, 8:31 am
Aim immunotech to present at the h.c. wainwright 24th annual global investment conference
OCALA, Fla., Sept. 07, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company fo...
September 7, 2022, 7:25 am
Nuvalent to present preliminary phase 1 data from arros-1 clinical trial of nvl-520 at 34th eortc-nci-aacr symposium and announces pipeline updates
Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Precli...
September 7, 2022, 6:30 am
Poseida therapeutics: collaboration agreement with roche helps validate genetic engineering tech
Poseida announced a collaboration agreement on Aug.3 focused on allogeneic CAR-T Program in hematologic cancer...
September 4, 2022, 3:30 am
Imv inc. to present at two investor conferences in september
DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company dev...
September 1, 2022, 7:05 am
Imv inc. to announce second quarter 2022 results and host a conference call and webcast on august 11, 2022
DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or “the Company�...
August 4, 2022, 7:05 am
Volitionrx limited inks r&d collaboration deals with xenetic biosciences and salarius pharmaceuticals in push to develop cancer treatments
VolitionRx (NYSE-A:VNRX) Limited has inked a pair of research and development collaborations that will develop targeted, adoptive cell therapies to ...
August 2, 2022, 10:07 am
Revolution medicines to report financial results for second quarter 2022 after market close on august 9, 2022
REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel ...
July 28, 2022, 4:02 pm
Why is neximmune (nexi) stock up 30% today?
NexImmune appears to be making headway in the company's ongoing battle against HPV-related cancers -- a...
July 15, 2022, 11:55 am
Amazon launches cancer vaccine clinical trial in partnership with fred hutchinson
Amazon is listed as a collaborator on a filing for an FDA-approved clinical trial, which seeks to develop vaccines to treat breast and skin ...
July 12, 2022, 9:31 am
Exor: another step into healthcare
Founded 125 years ago in Lyon, the group controlled by the Mérieux family is active in research on infectious diseases and ...
July 11, 2022, 5:44 pm
Harpoon therapeutics: a t-cell engager platform and a negative enterprise value makes it a candidate for my 'bio boom' portfolio
Harpoon Therapeutics has an intriguing platform that can generate stable bispecific immunotherapies using their TriTAC technology. Their “off-the-sh...
July 7, 2022, 5:34 pm
Pyxis oncology to present at h.c. wainwright preclinical cancer drug discovery conference
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation the...
June 28, 2022, 6:35 am
Aim immunotech boosts intellectual property with new netherlands utility patent covering ampligen and dsrna products aimed at covid-19
AIM ImmunoTech Inc (NYSE:AIM) revealed that the Netherlands Patent Office (Octrooicentrum Nederland) has issued Patent No 2027383 - a utility patent ...
June 13, 2022, 10:02 am
Revolution medicines to participate in the 43rd annual goldman sachs global healthcare conference
REDWOOD CITY, Calif., June 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing target...
June 9, 2022, 4:02 pm